Anthem Biosciences Ltd
NSE:ANTHEM
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
Anthem Biosciences Ltd
NSE:ANTHEM
|
IN |
|
Romande Energie Holding SA
SIX:HREN
|
CH |
|
Apple Hospitality REIT Inc
NYSE:APLE
|
US |
Wall St Price Targets
ANTHEM Price Targets Summary
Anthem Biosciences Ltd
According to Wall Street analysts, the average 1-year price target for ANTHEM is 902.02 INR with a low forecast of 838.3 INR and a high forecast of 1 003.8 INR.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is ANTHEM's stock price target?
Price Target
902.02
INR
According to Wall Street analysts, the average 1-year price target for ANTHEM is 902.02 INR with a low forecast of 838.3 INR and a high forecast of 1 003.8 INR.
What is the Revenue forecast for Anthem Biosciences Ltd?
Projected CAGR
18%
Over the last 1 year, the compound annual growth rate for Revenue has been 30%. The projected CAGR for the next 4 years is 18%.
What is the Gross Profit forecast for Anthem Biosciences Ltd?
Projected CAGR
21%
Over the last 1 year, the compound annual growth rate for Gross Profit has been 34%. The projected CAGR for the next 4 years is 21%.
What is the Operating Income forecast for Anthem Biosciences Ltd?
Projected CAGR
23%
Over the last 1 year, the compound annual growth rate for Operating Income has been 37%. The projected CAGR for the next 4 years is 23%.
What is the Pre-Tax Income forecast for Anthem Biosciences Ltd?
Projected CAGR
20%
Over the last 1 year, the compound annual growth rate for Pre-Tax Income has been 38%. The projected CAGR for the next 3 years is 20%.
What is the Net Income forecast for Anthem Biosciences Ltd?
Projected CAGR
26%
Over the last 1 year, the compound annual growth rate for Net Income has been 23%. The projected CAGR for the next 4 years is 26%.
